3002.12.00.30/RhoGAM Human Immune Serum/Japan

RhoGAM Human Immune Serum from Japan

RhoGAM is a human immune globulin derived from plasma containing antibodies against the Rho(D) antigen, used to prevent Rh hemolytic disease in newborns. It qualifies under HTS 3002.12.0030 as human immune blood sera prepared for prophylactic use in preventing alloimmunization in Rh-negative mothers. This sterile, injectable product is biotechnologically processed from human plasma.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Obtain FDA biologics license application (BLA) approval and ensure cold chain documentation for plasma products to maintain potency

• Provide certificates of analysis verifying human plasma origin and absence of adventitious agents per 21 CFR 630

• Avoid misclassification as non-immune sera; confirm immunological activity via donor screening records

RhoGAM Human Immune Serum from Japan — Import Duty Rate | HTS 3002.12.00.30